| Miss Brittney Dion Raby, MS CCC-SLP, L-SLP | |
|
7206 Juno Dr, Baker, LA 70714-5312 | |
| (225) 341-9141 | |
| Not Available |
| Full Name | Miss Brittney Dion Raby |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7206 Juno Dr, Baker, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649655523 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 6759 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Brittney Dion Raby, MS CCC-SLP, L-SLP 7206 Juno Dr, Baker, LA 70714-5312 Ph: (225) 341-9141 | Miss Brittney Dion Raby, MS CCC-SLP, L-SLP 7206 Juno Dr, Baker, LA 70714-5312 Ph: (225) 341-9141 |
News Archive
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the completion of its initial public offering of six million shares of common stock at a price of $7.00 per share. The net proceeds of the offering to Anthera, after deducting underwriting discounts and commissions and estimated offering expenses payable by Anthera, were approximately $36.7 million.
The U.S. Food and Drug Administration today announced class-wide safety labeling changes and new postmarket study requirements for all extended-release and long-acting opioid analgesics intended to treat pain.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, at the 2007 annual meeting of the American Psychiatric Association.
No matter where they came from, people born outside the United States but working here are much less likely to receive Social Security Disability Insurance benefits than those born in the U.S. or its territories. Foreign-born adults, according to a study published in the December issue of the journal Demography, are less likely to report health-related impediments to working, to be covered by work-disability insurance, and to apply for disability benefits.
Oxford Gene Technology, The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT's board.
› Verified 1 days ago
Mrs. Michelle Winfrey Reado, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3802 Myrtle St, Baker, LA 70714 Phone: 225-775-2562 | |
Darnisha Atrice Ruth, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4971 Groom Rd, Baker, LA 70714 Phone: 225-775-7051 Fax: 225-774-7244 | |
Iris G. King, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Felton St, Baker, LA 70714 Phone: 225-610-9390 | |
Ms. Andrea Monique Branch, M.ED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12812 Driftwood Dr, Baker, LA 70714 Phone: 225-775-6535 Fax: 225-324-8709 |